secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-06-18T23:59:59+00:00
Accession:  0001217234-24-000071
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx stockholders elect three Class I directors and approve 2024 Equity Incentive Plan
--------------------------------------------------------------------------------

- George W. Bickerstaff III, Christine M. Cournoyer, and Hannah Valantine, M.D. elected as Class I directors, terms expiring 2027.
- Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2024, with 47.1M votes for.
- Advisory approval of named executive officer compensation: 38.9M for, 1.6M against.
- 2024 Equity Incentive Plan approved (23.4M for, 16.6M against); authorizes up to 3.5M shares for equity awards.
- Approximately 91% of outstanding shares (47.4M of 52.0M) represented at meeting, establishing strong quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000071/0001217234-24-000071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000071/cdna-20240613.htm
  HTML page:      https://secwatch.observer/filing/0001217234-24-000071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer